Influenza News and Research

Latest Influenza News and Research

A summary of SARS-CoV-2 RNA-protein interactome studies

A new study summarized the importance of SARS-CoV-2 ribonucleic acid protein interactomes in the study of RNA viruses.

30 Mar 2022

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Researchers demonstrated that E proteins of β-coronaviruses could restrict HIV-1 infection.

30 Mar 2022

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

A new study shows that multiple variants of this virus may coinfect the same patient, using both genomic sequencing data and computational models.

30 Mar 2022

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapeutics for treating COVID-19 and other diseases, wherein furin is integral for their pathogenicity and progression.

29 Mar 2022

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

In a new study, researchers tested the bi-, tri-, and tetravalent formulations of Newcastle disease virus (NDV)-based low-cost vaccine in mice.

29 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.

29 Mar 2022

Is COVID-19 vaccination during pregnancy safe?

A new retrospective cohort study conducted across a large population of pregnant women in Ontario, Canada, has confirmed that the coronavirus disease 2019 (COVID-19) vaccination administered during pregnancy is not associated with any increased risk of adverse maternal or neonatal peripartum outcomes.

29 Mar 2022

Evaluating severity of influenza infection in ferrets with COVID-19 history

In a new study, researchers investigated the effect of SARS-CoV-2 exposure on the severity of influenza in ferrets.

28 Mar 2022

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Researchers evaluated the neurological complications due to SARS-CoV-2 D614G strain, and variants of concern, Delta and Omicron in a hamster model.

28 Mar 2022

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Researchers designed a dynamic mathematical model to simulate the transmission of the SARS-CoV-2 Omicron variant in China and project its associated burden on healthcare facilities, should the zero-COVID-19 policy be lifted.

28 Mar 2022

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

A recent study investigated the disease severity of SARS-CoV-2 Omicron BA.2 infection among Hong Kong children.

28 Mar 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Combination of Covid-19 and flu linked to greater risk of severe disease, death

Adults in hospital who have Covid-19 and the flu at the same time are at much greater risk of severe disease and death compared with patients who have Covid-19 alone or with other viruses, research shows.

27 Mar 2022

New method for generating binding proteins solves a long-standing challenge in drug development

A team of scientists has created a powerful new method for generating protein drugs. Using computers, they designed molecules that can target important proteins in the body, such as the insulin receptor, as well as vulnerable proteins on the surface of viruses.

25 Mar 2022

Influenza News and Research

Latest Influenza News and Research

A summary of SARS-CoV-2 RNA-protein interactome studies

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Algal metabolites as novel drugs against viruses

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Is COVID-19 vaccination during pregnancy safe?

Evaluating severity of influenza infection in ferrets with COVID-19 history

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

CDK6: a potential drug target for severe COVID-19

Combination of Covid-19 and flu linked to greater risk of severe disease, death

New method for generating binding proteins solves a long-standing challenge in drug development

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study evaluates the clinical accuracy of two FDA-approved rapid antigen tests across SARS-CoV-2 variants

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in